ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1627

Assessment of Myocardial Dysfunction Using Speckle Tracking Echocardiography in Patients with Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis

Volkan Emren1, Onay Gercik2, Emre Ozdemir3, Dilek Solmaz2, Nihan Eren3, Mehmet Tokac3, Gökhan Kabadayı2, Sercan Gucenmez2 and Servet Akar4, 1Faculty Of Medicine, Department of Cardiology, Izmir Katip Celebi University, Izmir, Turkey, 2Rheumatology, Izmir Katip Celebi University, Faculty of Medicine, Izmir, Turkey, 3Faculty Of Medicine, Department Of Cardiology, Izmir Katip Celebi University, Izmir, Turkey, 4Faculty of Medicine, Department of Rheumatology, Izmir Katip Celebi University, Izmir, Turkey

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: ankylosing spondylitis (AS) and axial spondyloarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster II: Clinical/Epidemiology Studies

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Axial spondyloarthritis (axSpA) is a chronic inflammatory disease that mainly affects axial skeleton. Although some differences like sex and objective signs of inflammation were described between ankylosing spondylitis and non-radiographic (nr-) axSpA patients, overall disease burden was found to be similar in these subgroups of axSpA. The association of chronic inflammation with cardiac dysfunction was well documented in many inflammatory rheumatic diseases. However it was not assessed in the subgroups of axSpA. Advanced two-dimensional (2D) speckle tracking echocardiographic analysis is more sensitive and accurate method of early detection of myocardial dysfunction than the conventional 2D transthoracic echocardiography (TTE).Therefore the aim of this study was to evaluate the left ventricular function by using speckle tracking echocardiography in patients with both r- and nr-axSpA.

Methods: In total 72 patients with ankylosing spondylitis (72% male) and age– and sex-matched 38 patients with nr-axSpA (58% male) and 56 healthy control subjects (54% male) were included in the analysis. Patients with hypertension, diabetes and known cardiac disease were excluded. All patients underwent detailed echocardiographic examination including M-mode, pulsed-wave Doppler imaging, pulsed-wave tissue Doppler imaging and 2D speckle tracking.

Results: Age and sex distribution were not different between groups. Some demographic and disease related characteristics were shown in the table. BASDAI, BASFI, global assessment of disease activity and ASAS-HI scores were found to be similar between r- and nr-axSpA patient groups. Although ejection fraction (EF) (P=0.449) and the other echocardiographic variables were similar between groups, global longitudinal strain (GLS) (P=0.004) was found to be different among groups (table) in ANOVA analysis. Post-hoc tests showed that GLS was similar between nr-axSpA and control groups however GLS was significantly low in r-axSpA patients. In univariate analysis GLS was correlated with age (P=0.032) and peripheral arthritis (P=0.035). However in regression analysis peripheral arthritis (P=0.009) was found as the only independent predictor of GLS.

Conclusion: The results of the present study showed that left ventricular function had impaired in ankylosing spondylitis patients and impaired ventricular function might also be the other differentiating factor between radiographic and nr-axSpA patients.

Table. The demographic and disease related characteristics of study groups.

Ankylosing Spondylitis

(n=72)

Non-radiographic axSpA patients

(n=38)

Control subjects

(n=56)

p

Age, years (mean ± SD)

39.2 ± 9.9

37.0 ± 10.6

40.9 ± 7.2

0.137

Duration of disease, years (mean ± SD)

12.9 ± 8.1

8.0 ± 7.8

N/A

N/A

BASDAI, (mean ± SD)

2.8 ± 2.3

3.0 ± 1.7

N/A

N/A

BASFI, (mean ± SD)

2.7 ± 2.5

2.2 ± 1.9

N/A

N/A

Ejection fraction, (mean ± SD)

59.2 ± 5.3

59.9 ± 4.6

60.3 ± 4.6

0.449

Global Longitudinal Strain, (mean ± SD)

20.5 ± 3.3

21.1 ± 3.5

22.3 ± 2.4

0.004


Disclosure: V. Emren, None; O. Gercik, None; E. Ozdemir, None; D. Solmaz, None; N. Eren, None; M. Tokac, None; G. Kabadayı, None; S. Gucenmez, None; S. Akar, None.

To cite this abstract in AMA style:

Emren V, Gercik O, Ozdemir E, Solmaz D, Eren N, Tokac M, Kabadayı G, Gucenmez S, Akar S. Assessment of Myocardial Dysfunction Using Speckle Tracking Echocardiography in Patients with Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/assessment-of-myocardial-dysfunction-using-speckle-tracking-echocardiography-in-patients-with-ankylosing-spondylitis-and-nonradiographic-axial-spondyloarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/assessment-of-myocardial-dysfunction-using-speckle-tracking-echocardiography-in-patients-with-ankylosing-spondylitis-and-nonradiographic-axial-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology